ECM
Endurant Capital Management Portfolio holdings
AUM
$17.4M
This Quarter Return
-4.37%
1 Year Return
+4.95%
3 Year Return
+16.8%
5 Year Return
+58.39%
10 Year Return
–
AUM
$331M
AUM Growth
-$38.5M
(-10%)
Cap. Flow
-$17.7M
Cap. Flow
% of AUM
-5.34%
Top 10 Holdings %
Top 10 Hldgs %
52.13%
Holding
90
New
22
Increased
20
Reduced
16
Closed
27
Top Buys
| 1 |
Bristol-Myers Squibb
BMY
|
$14.2M |
| 2 |
Orthofix Medical
OFIX
|
$13.6M |
| 3 |
Centene
CNC
|
$12.4M |
| 4 |
McKesson
MCK
|
$8.93M |
| 5 |
Avantor
AVTR
|
$6.05M |
Top Sells
| 1 |
Sanofi
SNY
|
$21.3M |
| 2 |
Cencora
COR
|
$15.3M |
| 3 |
Dentsply Sirona
XRAY
|
$9.62M |
| 4 |
Becton Dickinson
BDX
|
$8.66M |
| 5 |
SI-BONE Inc
SIBN
|
$7.99M |
Sector Composition
| 1 | Healthcare | 80.72% |
| 2 | Industrials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Natera
NTRA
$23B
| $1.01M | 0.27% |
+24,747
| New | +$1.01M |
|
52
Kezar Life Sciences
KZR
$28.5M
| $988K | 0.26% |
+5,947
| New | +$988K |
|
53
Charles River Laboratories
CRL
$7.86B
| $939K | 0.25% |
3,308
-15,278
| -82% | -$4.34M |
|
54
Praxis Precision Medicines
PRAX
$978M
| $811K | 0.21% |
5,297
-674
| -11% | -$103K |
|
55
Gossamer Bio
GOSS
$598M
| $596K | 0.16% |
68,710
-44,950
| -40% | -$390K |
|
56
DarioHealth
DRIO
$24.4M
| $431K | 0.11% |
3,689
-860
| -19% | -$100K |
|
|
PHAS
57
DELISTED
PhaseBio Pharmaceuticals, Inc. Common Stock
PHAS
| $322K | 0.08% |
243,795
-116,283
| -32% | -$154K |
|
58
Biodesix
BDSX
$71.5M
| $221K | 0.06% |
+130,753
| New | +$221K |
|
59
AngioDynamics
ANGO
$432M
| – | – |
-18,125
| Closed | -$500K |
|
60
Accuray
ARAY
$166M
| – | – |
-245,764
| Closed | -$1.17M |
|
61
Actinium Pharmaceuticals
ATNM
$53.3M
| – | – |
-66,666
| Closed | – |
|
62
AtriCure
ATRC
$1.72B
| – | – |
-24,253
| Closed | -$1.69M |
|
63
Aurinia Pharmaceuticals
AUPH
$1.61B
| – | – |
-66,935
| Closed | -$1.53M |
|
|
64
Becton Dickinson
BDX
$54.3B
| – | – |
-35,313
| Closed | -$8.66M |
|
|
65
Cencora
COR
$57.5B
| – | – |
-115,003
| Closed | -$15.3M |
|
66
Community Health Systems
CYH
$394M
| – | – |
-44,847
| Closed | -$597K |
|
67
DaVita
DVA
$9.77B
| – | – |
0
| – | – |
|
68
Heron Therapeutics
HRTX
$199M
| – | – |
-165,404
| Closed | -$1.51M |
|
69
iShares Russell 2000 ETF
IWM
$66.9B
| – | – |
0
| – | – |
|
70
Johnson & Johnson
JNJ
$430B
| – | – |
-42,762
| Closed | -$7.32M |
|
71
Kiniksa Pharmaceuticals
KNSA
$2.63B
| – | – |
-244,125
| Closed | -$2.87M |
|
72
Nurix Therapeutics
NRIX
$709M
| – | – |
-43,542
| Closed | -$1.26M |
|
73
Owens & Minor
OMI
$416M
| – | – |
-22,489
| Closed | -$978K |
|
74
SPDR S&P 500 ETF Trust
SPY
$658B
| – | – |
0
| – | – |
|
75
Sarepta Therapeutics
SRPT
$1.95B
| – | – |
-33,191
| Closed | -$2.99M |
|